Daunorubicin and constipation Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4788066-0
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 04, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , body temperature increased, constipation , hypotension, ileus, neutropenia, ventricular extrasystoles. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, FAMOTIDINE, FENTANYL, MEROPENEM. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5224689-2
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, weighting 43.30 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal distension, cardio-respiratory arrest, constipation , gallbladder disorder, gallbladder oedema, hypotension, neutropenia, pneumatosis, sepsis . Daunorubicin dosage: 19.3 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE, BACTRIM. Patient recovered.

Daunorubicin Side Effects Report #5078644-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, weighting 117.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , atrophic vulvovaginitis, constipation , diverticulum, faecal volume increased, haemorrhoids, neutropenia, rectal haemorrhage. Daunorubicin dosage: 270 MG. During the same period patient was treated with DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5465330-3
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Male patient, weighting 138.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: colitis, constipation , faecaloma, febrile neutropenia, gastritis, gastrointestinal necrosis, hyponatraemia, inappropriate antidiuretic hormone secretion, large intestine perforation. Daunorubicin dosage: 172 MG. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.